Fraunhofer IGB Advances Cell Therapy R&D Using Automated NGS Data Analysis Workflows

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is a leading research institute that develops and optimizes processes, technologies, and products for health, sustainable chemistry, and the environment. Within Fraunhofer IGB, the Functional Genomics research group uses next-generation sequencing (NGS) assays to support variety of applications including biomarker identification, infection process analysis, and cell and gene therapy development.
 

By automating NGS data analysis with Genedata Selector^®, Fraunhofer IGB boosts productivity and eliminates tedious manual, error-prone tasks while empowering even scientists without a bioinformatics background to quickly interpret results. The software platform acts as a central hub for all NGS data, with which the Institute can efficiently generate knowledge and facilitate data-driven decision-making, accelerating innovation for their biopharma industry partners.